Holm P - Search Results

1

Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism.

Kalliovalkama J, Jolma P, Tolvanen JP, Kähönen M, Hutri-Kähönen N, Wu X, Holm P, Pörsti I. Kalliovalkama J, et al. Among authors: holm p. Cardiovasc Res. 1999 Jun;42(3):773-82. doi: 10.1016/s0008-6363(98)00346-0. Cardiovasc Res. 1999. PMID: 10533618

2

The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo.

Holm P, Liska J, Franco-Cereceda A. Holm P, et al. Cardiovasc Res. 1998 Mar;37(3):765-71. doi: 10.1016/s0008-6363(97)00291-5. Cardiovasc Res. 1998. PMID: 9659461

3

Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits.

Holm P, Korsgaard N, Shalmi M, Andersen HL, Hougaard P, Skouby SO, Stender S. Holm P, et al. J Clin Invest. 1997 Aug 15;100(4):821-8. doi: 10.1172/JCI119597. J Clin Invest. 1997. PMID: 9259581 Free PMC article.

4

Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.

Holm P. Holm P. Scand Cardiovasc J Suppl. 1997;46:1-40. Scand Cardiovasc J Suppl. 1997. PMID: 9265559 Review.

5

Selective or nonselective endothelin antagonists in porcine hypoxic pulmonary hypertension?

Franco-Cereceda A, Holm P. Franco-Cereceda A, et al. Among authors: holm p. J Cardiovasc Pharmacol. 1998;31 Suppl 1:S447-52. doi: 10.1097/00005344-199800001-00128. J Cardiovasc Pharmacol. 1998. PMID: 9595509

6

Estrogen receptor-mediated, nitric oxide-dependent modulation of the immunologic barrier function of the endothelium: regulation of fas ligand expression by estradiol.

Amant C, Holm P, Xu Sh SH, Tritman N, Kearney M, Losordo DW. Amant C, et al. Among authors: holm p. Circulation. 2001 Nov 20;104(21):2576-81. doi: 10.1161/hc4601.099406. Circulation. 2001. PMID: 11714653

7

Tissue concentrations of endothelins and functional effects of endothelin-receptor activation in human arteries and veins.

Holm P, Franco-Cereceda A. Holm P, et al. J Thorac Cardiovasc Surg. 1996 Aug;112(2):264-72. doi: 10.1016/S0022-5223(96)70248-9. J Thorac Cardiovasc Surg. 1996. PMID: 8751489 Free article.

8

ET-1 infusion increases systemic vascular resistance and depresses cardiac output in patients with chronic hypoxaemia and pulmonary hypertension.

Franco-Cereceda A, Holm P, Brodin LA, Liska J, Larsen FF. Franco-Cereceda A, et al. Among authors: holm p. Scand Cardiovasc J. 1999;33(3):151-6. doi: 10.1080/14017439950141777. Scand Cardiovasc J. 1999. PMID: 10399802 Free article.

9

Endothelin infusion reduces hypoxic pulmonary hypertension in pigs in vivo.

Liska J, Holm P, Owall A, Franco-Cereceda A. Liska J, et al. Among authors: holm p. Acta Physiol Scand. 1995 Aug;154(4):489-98. doi: 10.1111/j.1748-1716.1995.tb09934.x. Acta Physiol Scand. 1995. PMID: 7484175

10

The endothelin antagonist bosentan: hemodynamic effects during normoxia and hypoxic pulmonary hypertension in pigs.

Holm P, Liska J, Clozel M, Franco-Cereceda A. Holm P, et al. J Thorac Cardiovasc Surg. 1996 Oct;112(4):890-7. doi: 10.1016/S0022-5223(96)70088-0. J Thorac Cardiovasc Surg. 1996. PMID: 8873714 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters